EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum CD93 as a Potential Diagnostic Biomarker for Endometrial Cancer: A Case–Control Study

İsmail Bağlar iD, Fatih Şanlıkan iD, Esra Keles iD, Sahra Sultan Kara iD, Cansu Ergenç Özdaş iD, Yeliz Çeçen Dönmez, Hafize Uzun iD

Journal of Clinical Medicine · 29.04.2026 · 15 (9) · 3409

DOI: 10.3390/jcm15093409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.04.2026. Verfasst von İsmail Bağlar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, 34865 Istanbul, Türkiye. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

CD93, an angiogenesis-related transmembrane glycoprotein, is transcriptomically downregulated in uterine corpus endometrial carcinoma, yet circulating protein levels have not been clinically evaluated. This study aimed to evaluate serum CD93 as a diagnostic biomarker for EC and to examine its association with clinicopathological parameters.

Methods

In this single-center case–control study, serum CD93 concentrations were measured by enzyme-linked immunosorbent assay in 46 patients with histologically confirmed primary EC and 35 controls with histologically verified benign gynecological pathology. Logistic regression and receiver operating characteristic (ROC) curve analyses were performed.

Results

Serum CD93 was significantly lower in EC patients than controls (median 4.55 [IQR 3.51–6.97] vs. 10.24 [7.18–12.14] ng/mL; p < 0.001). In multivariable analysis adjusted for age and body mass index, lower CD93 remained independently associated with EC (OR = 0.521; 95% CI 0.061–0.720; p < 0.001). ROC analysis yielded an area under the curve of 0.845 (95% CI 0.759–0.921), with 82.6% sensitivity and 74.3% specificity at a cut-off of 7.338 ng/mL. CD93 levels showed no significant association with histological subtype, grade, lymphovascular space invasion, nodal metastasis, or recurrence.

Conclusions

Serum CD93 is significantly reduced in EC and demonstrates independent diagnostic performance, supporting its prospective validation as a non-invasive biomarker in larger multicenter cohorts.

Schlagwörter

Stichwörter der Autor:innen

CD93angiogenesiscirculating biomarkerdiagnostic accuracyectodomain sheddingendometrial cancer

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, 34865 Istanbul, Türkiye.
  • Department of Gynecologic Oncology, University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, 34865 Istanbul, Türkiye.
  • Management Department, Business School, Ankara Yildirim Beyazit University, 06010 Ankara, Türkiye.
  • Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Türkiye.

ORCID-Profile: İsmail Bağlar, Fatih Şanlıkan, Esra Keles, Sahra Sultan Kara, Cansu Ergenç Özdaş, Hafize Uzun

Zitieren

APA

Bağlar, İ., Şanlıkan, F., Keles, E., Kara, S. S., Özdaş, C. E., Dönmez, Y. Ç., & Uzun, H. (2026). Serum CD93 as a Potential Diagnostic Biomarker for Endometrial Cancer: A Case–Control Study. Journal of Clinical Medicine, 15(9), 3409. https://doi.org/10.3390/jcm15093409

Vancouver

Bağlar İ, Şanlıkan F, Keles E, Kara SS, Özdaş CE, Dönmez YÇ, et al. Serum CD93 as a Potential Diagnostic Biomarker for Endometrial Cancer: A Case–Control Study. Journal of Clinical Medicine. 2026;15(9):3409. doi:10.3390/jcm15093409

BibTeX
@article{Balar2026,
  author = {Bağlar, İsmail and Şanlıkan, Fatih and Keles, Esra and Kara, Sahra Sultan and Özdaş, Cansu Ergenç and Dönmez, Yeliz Çeçen and Uzun, Hafize},
  title = {Serum CD93 as a Potential Diagnostic Biomarker for Endometrial Cancer: A Case–Control Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {9},
  pages = {3409},
  doi = {10.3390/jcm15093409}
}
Kostenlos starten →